| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.28 | 0.07 |